Skip to Main Content

Author Details

Aram Vosoughi
H. Lee Moffitt Cancer Center and Research Institute
2013
22
8
PMIDPaper TitleJournal TitlePublished Year
37802683Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.Eur Urol2024
36975458Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension.Curr Oncol2023
37546702The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.Cancer Res Commun2023
37880002Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer.Urol Oncol2023
37217696Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.Nat Rev Urol2023
36977797Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.Nat Rev Urol2023
35178262Colonic Adenocarcinoma with Plasmacytoid Feature: Histopathology and Molecular Characteristics of a Rare Neoplasm with an Unusual Presentation.Case Rep Pathol2022
36010582Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma.Cells2022
32732113The Paris System "atypical urothelial cells" category: can the current criteria be improved?J Am Soc Cytopathol2021
32546017Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer.Expert Rev Mol Diagn2020
33273457Common germline-somatic variant interactions in advanced urothelial cancer.Nat Commun2020
32332823Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.Nat Commun2020
30333152Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.Mol Cancer Res2019
30894499Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.Sci Transl Med2019
30655535ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun2019
29723604Frozen section evaluation via dynamic real-time nonrobotic telepathology system in a university cancer center by resident/faculty cooperation team.Hum Pathol2018
29921838Patient derived organoids to model rare prostate cancer phenotypes.Nat Commun2018
28274793PKK deficiency in B cells prevents lupus development in Sle lupus mice.Immunol Lett2017
26008946Transverse myelitis presenting in a patient with Hughes-Stovin syndrome.Mult Scler Relat Disord2015
24510837Gene-based vaccination and screening methods to develop monoclonal antibodies.Methods Mol Biol2014
23280626Protein kinase Cβ is required for lupus development in Sle mice.Arthritis Rheum2013
23901083A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis.J Infect Dis2013
  • 1 - 22 of 22

Recommended Authors

University of California San Francisco
Career Start Year 2014
Number of shared co-authors 15
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2008
Number of shared co-authors 14
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 3
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 8
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 2
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 3
University of Toronto
Career Start Year 2006
Number of shared co-authors 5
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Career Start Year 2006
Number of shared co-authors 6
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 1
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 15
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 6
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 13
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 1
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 27
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 8
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 1
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 15
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 2
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 20
Queen's University
Career Start Year 1982
Number of shared co-authors 6
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 6

Collaborators

H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 6
University of Bern
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
Meyer Cancer Center
Co-authored papers 5
Sandra and Edward Meyer Cancer Center
Co-authored papers 4
Institute for Computational Biomedicine
Co-authored papers 4
Sandra and Edward Meyer Cancer Center
Co-authored papers 4
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 3
Institute for Pathology, University Hospital Schleswig-Holstein
Co-authored papers 3
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 3
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Foundation Medicine
Co-authored papers 2
Dartmouth-Hitchcock Medical Center
Co-authored papers 2
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
Weill Cornell Medical College
Co-authored papers 2
University of Trento
Co-authored papers 2
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 2
Meyer Cancer Center
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 1
New York Presbyterian Hospital-Weill Cornell
Co-authored papers 1
Case Western Reserve University
Co-authored papers 1
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers 1
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Meyer Cancer Center, Englander Institute for Precision Medicine
Co-authored papers 1
University of British Columbia
Co-authored papers 1